Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.

Brigand, C; Monneuse, O; Mohamed, F; Sayag-Beaujard, A C; Isaac, S; Gilly, F N; Glehen, O

Brigand, C; Monneuse, O; Mohamed, F; Sayag-Beaujard, A C; Isaac, S; Gilly, F N; Glehen, O.

Affiliation

Brigand C; Department of General Surgery, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.

Ann Surg Oncol ; 13(3): 405-12, 2006 Mar.

Article in En | MEDLINE | ID: mdl-16485159

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hyperthermia, Induced; Mesothelioma/drug therapy; Mesothelioma/surgery; Peritoneal Neoplasms/drug therapy; Peritoneal Neoplasms/surgery; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Cisplatin/administration & dosage; Combined Modality Therapy; Female; Humans; Intraoperative Period; Male; Middle Aged; Mitomycin/administration & dosage; Prospective Studies; Retrospective Studies; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Peritoneal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Hyperthermia, Induced / Mesothelioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Surg Oncol Year: 2006 Type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links